Client News
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
ONWARD Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury at Home
Galapagos Biopharma: Dr. Sabine Koken geht als neue Steuerfrau bei Galapagos Biopharma Deutschland an Bord
Carbios strengthens its organization with a view to business development and integrates new expertise key to bringing its innovations to market
ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022
Carbios: 2022 half-year results
InflaRx Submits Request for Emergency Use Authorization to US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients
AiCuris´ innovation accelerator AiCubator calls for innovative proposals to propel anti-infective drug development in the third round
ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
